Epidural Levobupivacaine-sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine
- Registration Number
- NCT01320475
- Lead Sponsor
- Hopital Foch
- Brief Summary
Thoracic epidural analgesia is often proposed to thoracotomized patients. A local anesthetic and an opioid are generally associated to produce an epidural analgesia. However, opioid epidural administration is frequently associated with adverse effects as nausea, vomiting, urinary retention, ... On the other hand, iv ketamine has been demonstrated to be an effective analgesic.
The purpose of the study is to compare the epidural administration of levobupivacaine and sufentanil or the epidural administration of levobupivacaine associated with the iv administration of ketamine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 2
- age between 18 and 75 yrs
- class ASA I, II or III
- lung surgery
- Contra-indication to the achievement of epidural analgesia
- Preoperative chronic pain,
- Contra-indication to ketamine
- Hypersensitivity to ketamine or any excipients
- Uncontrolled hypertension,
- Stroke
- Heart failure
- Hepatic porphyria
- Contra-indication to sufentanil
- Hypersensitivity to sufentanil, opioids or any excipients
- Treatment with an opioid agonist-antagonist,
- Contra-indication to levobupivacaine
- Hypersensitivity to levobupivacaine, local anesthetics of the amide or any excipients
- Hypotension, shock
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description iv Ketamine Ketamine Epidural infusion of levobupivacaine and saline (placebo for sufentanil)and iv infusion of ketamine Up to the third postoperative day (6 PM) Sufentanil Sufentanil Epidural infusion of levobupivacaine (1,25 mg/ml) and sufentanil(1 ml = 50 µg diluted in the 200 ml bag of levobupivacaine) IV infusion of saline (placebo for ketamine)
- Primary Outcome Measures
Name Time Method Efficacy of the analgesic regimen third postoperative day Occurrence of an adverse event due to the analgesic protocol one week
- Secondary Outcome Measures
Name Time Method postoperative complications (pulmonary, others) one month length of stay one month patient's satisfaction sortie de l'hopital postoperative rehabilitation two weeks Occurence of a chronic pain end the first postoperative year
Trial Locations
- Locations (1)
Hopital Foch
🇫🇷Suresnes, France